Dose- and time-dependent expression of anxiety-like behavior in the elevated plus-maze during withdrawal from acute and repeated intermittent ethanol intoxication in rats

被引:48
作者
Zhang, Zhongqi
Morse, Andrew C.
Koob, George F.
Schulteis, Gery
机构
[1] UC San Diego Sch Med, Dept Anesthesiol, San Diego, CA 92161 USA
[2] VA San Diego Healthcare Syst, San Diego, CA 92161 USA
[3] Scripps Res Inst, Comm Neurobiol Addict Disorders, La Jolla, CA USA
关键词
acute withdrawal; dependence; abstinence; anxiety;
D O I
10.1111/j.1530-0277.2007.00483.x
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Background: Withdrawal from acute bolus intraperitoneal (IP) injection of high doses of ethanol elicits anxiety-like behavior (e.g. Doremus et al., 2003; Gauvin et al., 1989, 1992) and conditioned place aversion (Morse et al., 2000). More recently we demonstrated that withdrawal from a single moderate dose of ethanol (2.0 g/kg) is accompanied by elevations in brain reward thresholds, and that repeated intermittent treatment with this dose results in a significant potentiation of reward deficit (Schulteis and Liu, 2006). Methods: In the current study, the time- and dose-dependent emergence of anxiety-like behavior was measured in the elevated plus-maze at various times (3 to 24 hours) after acute or 3 daily IP injections of ethanol (1.0, 2.0, or 3.0 g/kg). Rats receiving daily handling for 2 days, and a single anxiety opportunity to explore the maze on a third day were divided into 1 of several treatment protocols: (1) NAIVE conditions: vehicle IP on all 3 days; (2) ACUTE conditions: vehicle on the first 2 days, ethanol on the third day; or (3) REPEAT conditions: ethanol on all 3 days. Results: ACUTE ethanol elicited reduced exploration of the open arms of the elevated plus-maze in a dose- and time-dependent fashion: 1.0 g/kg failed to elicit any significant effects, whereas 2.0 and 3.0 g/kg ethanol elicited a significant anxiety-like response at 6 hours and 9 to 12 hours postinjection, respectively. REPEAT treatment was still without effect at any time point tested following 1.0 g/kg ethanol, but extended the time course of anxiety-like behavior after treatment with either 2.0 or 3.0 g/kg doses. REPEAT treatment with 2.0 and 3.0 g/kg ethanol also produced significant hypoactivity in the maze at some time points postinjection. Conclusions: Withdrawal from a single exposure to ethanol produces transient but significant anxiety-like behavior, and repeated intermittent bouts of intoxication result in a significant extension of the duration of effect. The rapid emergence and progression of negative emotional signs of withdrawal may be a significant factor in determining susceptibility to transition from casual drinking to loss of control and escalating patterns of consumption that result in alcoholism.
引用
收藏
页码:1811 / 1819
页数:9
相关论文
共 74 条
[1]   Gender in relation to relapse crisis situations, coping, and outcome among treated alcoholics [J].
Annis, HM ;
Sklar, SM ;
Moser, AE .
ADDICTIVE BEHAVIORS, 1998, 23 (01) :127-131
[2]  
[Anonymous], DRUG ALCOHOL ABUSE C
[3]   POTENTIATION OF ETHANOL WITHDRAWAL BY PRIOR DEPENDENCE [J].
BAKER, TB ;
CANNON, DS .
PSYCHOPHARMACOLOGY, 1979, 60 (02) :105-110
[4]   CRF ANTAGONIST REVERSES THE ANXIOGENIC RESPONSE TO ETHANOL WITHDRAWAL IN THE RAT [J].
BALDWIN, HA ;
RASSNICK, S ;
RIVIER, J ;
KOOB, GF ;
BRITTON, KT .
PSYCHOPHARMACOLOGY, 1991, 103 (02) :227-232
[5]   KINDLING AS A MODEL FOR ALCOHOL WITHDRAWAL SYNDROMES [J].
BALLENGER, JC ;
POST, RM .
BRITISH JOURNAL OF PSYCHIATRY, 1978, 133 (JUL) :1-14
[6]   Corticotropin-releasing factor antagonist attenuates the "anxiogenic-like" effect in the defensive burying paradigm but not in the elevated plus-maze following chronic cocaine in rats [J].
Basso, AM ;
Spina, M ;
Rivier, J ;
Vale, W ;
Koob, GF .
PSYCHOPHARMACOLOGY, 1999, 145 (01) :21-30
[7]   Repeated ethanol withdrawal experience increases the severity and duration of subsequent withdrawal seizures in mice [J].
Becker, HC ;
DiazGranados, JL ;
Weathersby, RT .
ALCOHOL, 1997, 14 (04) :319-326
[8]   Increased ethanol drinking after repeated chronic ethanol exposure and withdrawal experience in C57BL/6 mice [J].
Becker, HC ;
Lopez, MF .
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2004, 28 (12) :1829-1838
[9]  
Becker HC, 2000, ALCOHOL RES HEALTH, V24, P105
[10]   PROPRANOLOL FOR THE TREATMENT OF THE ALCOHOLIC HANGOVER [J].
BOGIN, RM ;
NOSTRANT, TT ;
YOUNG, MJ .
AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE, 1986, 12 (03) :279-284